Nemluvio — Blue Cross Blue Shield of Montana
atopic dermatitis
Initial criteria
- The requested quantity (dose) does NOT exceed the program quantity limit OR the criteria for quantities above limit met
- If the requested dose exceeds limit AND patient weighs <90 kg, initial loading dose request not exceeding FDA labeled maximum allowed
- If patient weighs ≥90 kg and requested quantity does NOT exceed 60 mg every 4 weeks
- If requested agent does not have maximum FDA labeled dose and there is support for higher dose
- If requested quantity does not exceed maximum FDA labeled dose and justification provided why alternative strength cannot meet dosing requirements
Approval duration
BCBSIL 12 months; others initial 4 months, renewal 12 months